News

LAPD opens investigation into Matthew Perry’s death

investigation

The Los Angeles Police Department has launched an investigation into the death of actor Matthew Perry, known for his role in the TV sitcom “Friends.”

Perry passed away in October, with medical officials attributing his death to the “acute effects of ketamine.”

The investigation aims to uncover how Perry obtained the anaesthetic ketamine, which was present in his system.

His death, ruled an accident, also listed drowning as a contributing factor.

On Tuesday, the LAPD confirmed it is collaborating with the Drug Enforcement Agency and the US Postal Inspection Service.

The status of the investigation, initially reported by TMZ, and details about those interviewed remain unclear.

Perry was discovered unresponsive in the pool of his Los Angeles home on October 28 and pronounced dead at the scene.

In December, the LA County medical examiner’s office reported “high levels of ketamine” in his post-mortem blood sample.

Senior deputy medical examiner Raffi Djabourian noted other factors, including coronary artery disease and the effects of buprenorphine, used for treating opioid use disorder.

Djabourian explained that “drowning contributes due to the likelihood of submersion into the pool as he lapsed into unconsciousness; coronary artery disease contributes due to exacerbation of ketamine-induced myocardial effects on the heart.”

investigation

At the time of his death, Perry was receiving medically supervised ketamine treatments for depression and anxiety.

However, his last prescribed treatment was over a week before his death.

Perry had a well-documented struggle with addiction to painkillers and alcohol, attending multiple rehabilitation clinics.

In a 2016 interview, he revealed he could not recall three years of filming “Friends” due to substance abuse.

Despite multiple attempts at treatment, Perry mentioned in his memoir that he had been mostly sober since 2001, “save for about 60 or 70 mishaps.”

Source-BBC

Tags

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close
Close